Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

AVITA MEDICAL LTD

INVESTOR PRESENTATION - AVITA MEDICAL LTD

ASX:AVH

AVITA MEDICAL LTD

Health Care

Avita Medical Ltd (AVH) is a medical technology company that develops and distributes regenerative and tissue-engineered products for the treatment of wounds, scars and skin defects. The company's products includes regenerative medicine products (ReCell Autologous Spray-On-Skin), ReGenercell and Renovacell.

Read more

Market Cap

532.40m

Price at Close

$6.96

4w avg. Volume

596.40k

4w avg. Turnover

$4.28m

Announcements
announcementt+2 movementdate
  • Appendix 3G

    Issued Capital

  • -

    24 Sep 2020

-

24 Sep 2020
  • Cleansing Notice

    Issued Capital

  • -

    24 Sep 2020

-

24 Sep 2020
  • Change of Director's Interest Notice - Michael Perry

    Shareholder Details

  • -4.94%

    21 Sep 2020

-4.94%

21 Sep 2020
  • Change of Director's Interest Notice - Michael Perry

    Shareholder Details

  • +2.08%

    16 Sep 2020

+2.08%

16 Sep 2020
  • Appendix 3G

    Issued Capital

  • +2.08%

    16 Sep 2020

+2.08%

16 Sep 2020
  • Cleansing Notice

    Issued Capital

  • +2.08%

    16 Sep 2020

+2.08%

16 Sep 2020
  • Non-Executive Director Resignation

    Company Administration

  • +4.05%

    14 Sep 2020

+4.05%

14 Sep 2020
  • Change of Director's Interest Notice - Michael Perry

    Shareholder Details

  • +4.05%

    14 Sep 2020

+4.05%

14 Sep 2020
  • Appendix 3G

    Issued Capital

  • +4.05%

    14 Sep 2020

+4.05%

14 Sep 2020
  • First Patient Enrolled in Vitiligo Pivotal Study

    Progress Report · Market sensitive

  • +4.05%

    13 Sep 2020

+4.05%

13 Sep 2020
Market Data

Current Price

$6.96

52WK HIGH

$9.11

52WK LOW

$0.325

1YR RETURN

+1060.00%

1YR RETURN VS. SECTOR

+1027.12%

90 DAY RETURN

-22.67%

ASX RANK

350

/2,018

SECTOR RANK

6

/47

SHARES OUTSTANDING

76.49m
ASX:AVH

AVITA MEDICAL LTD

Health Care

Avita Medical Ltd (AVH) is a medical technology company that develops and distributes regenerative and tissue-engineered products for the treatment of wounds, scars and skin defects. The company's products includes regenerative medicine products (ReCell Autologous Spray-On-Skin), ReGenercell and Renovacell.

Read more

Market Cap

532.40m

Price at Close

$6.96

4w avg. Volume

596.40k

4w avg. Turnover

$4.28m

ASX:AVH is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.